UPB vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

UPB

51.9
AI Score
VS
UPB Wins

CBIO

51.4
AI Score

Investment Advisor Scores

UPB

52score
Recommendation
HOLD

CBIO

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric UPB CBIO Winner
Revenue 2.20M 4.16M CBIO
Net Income -121.48M -85.85M CBIO
Net Margin -5517.0% -2065.6% CBIO
Operating Income -129.36M -91.00M CBIO
ROE -51.9% -31.3% CBIO
ROA -49.4% -28.7% CBIO
Total Assets 245.99M 299.50M CBIO
Cash 47.42M 289.36M CBIO
Current Ratio 20.45 12.57 UPB

Relative Price Performance (Last 90 Days)

UPB 1M: -16.4% · 3M: -59.5% CBIO 1M: +14.2% · 3M: -16.2%

Current Technical Phase

UPB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.3%), weak momentum, RSI 36

RSI (14): 36.4 · Price: $2.86

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $14.37

Fundamentals Snapshot

Metric UPB CBIO
Market Cap — —
Forward P/E -1.0 -5.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.4% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin -61.2% -14.3%
EPS -2.85 -7.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UPB is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.